denkapparat Operations’s BioMarin Pharmaceuticals BMRN Stock Holding History

denkapparat Operations’s Portfolio BMRN Stock Details BMRN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$716K	Hold	11,938	–	–	0.19%	212
2026 Q2	$683K	Hold	11,938	–	–	0.22%	184
2026 Q1	$674K	Sell	11,938 -1,886	-14%	-$110K	0.28%	138
2025 Q4	$822K	Buy	13,824 +2,756	+25%	+$150K	0.45%	77
2025 Q3	$599K	Buy	11,068 +3,442	+45%	+$197K	0.38%	98
2025 Q2	$419K	Buy	7,626 +500	+7%	+$29.4K	0.33%	120
2025 Q1	$504K	Buy	+7,126	New	+$479K	0.53%	67

Other funds holding BMRN

Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

Swedbank Stockholm, Sweden $118B AUM 40.52% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return

Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return

Russell Investments Group London, United Kingdom $114B AUM 33.83% 1-Year Est. Return

ARGA Investment Management Stamford, Connecticut $3.94B AUM 28.9% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $54.1B AUM 39.29% 1-Year Est. Return

Fort Washington Investment Advisors Cincinnati, Ohio $19.7B AUM 20.11% 1-Year Est. Return

Nuveen Charlotte, North Carolina $420B AUM 34.97% 1-Year Est. Return

denkapparat Operations's BMRN Position: Q3 2026 in Review

denkapparat Operations held its BioMarin Pharmaceuticals (BMRN) position steady in Q3 2026 at 11,938 shares worth $716K. The position accounts for 0.19% of the portfolio, ranked #212.

denkapparat Operations first reported a position in BMRN in Q1 2025 and has held it in 7 quarters since. The position peaked at $822K in Q4 2025. 280 funds tracked by Wall St. Rank hold BMRN as of Q3 2026.

denkapparat Operations held 11,938 shares of BioMarin Pharmaceuticals worth $716K as of Q3 2026.
denkapparat Operations left its BioMarin Pharmaceuticals share count unchanged in Q3 2026.
BioMarin Pharmaceuticals made up 0.19% of denkapparat Operations's portfolio in Q3 2026, its #212 holding.
denkapparat Operations first reported a position in BioMarin Pharmaceuticals in Q1 2025 and has held it in 7 quarters since.
denkapparat Operations's BioMarin Pharmaceuticals position peaked at $822K in Q4 2025.
280 funds tracked by Wall St. Rank held BioMarin Pharmaceuticals as of Q3 2026.

Based on denkapparat Operations's 13F filing for Q3 2026, filed 9 Nov 2026.